- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04430946
Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
Comparison of Postpradial Gut Hormone and Metabolic Responses Between Patients With Type 1 Diabetes Mellitus and Healthy Controls
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aim of the study
To compare the acute effect of the consumption of a test meal on satiety, gastrointestinal hormones' response, post-meal thermogenesis, and further metabolic parameters in lean patients with type 1 diabetes mellitus (T1DM), obese patients with T1DM, and healthy lean and obese controls.
Study subjects:
Four groups of participants will be recruited, consisting of 15 lean healthy subjects (BMI <25 kg/m2), 15 obese healthy subjects, 15 lean patients with T1DM (BMI <25 kg/m2), and 15 obese patients with T1DM (BMI ≥ 30kg/m2). Groups will be matched for age and sex. Healthy volunteers will be recruited from the community, and diabetic individuals from our diabetes clinic. Eligibility criteria will include 18-65 years of age, no use of medications affecting appetite and stable weight (no fluctuations exceeding 5 kg the last 3 months.
Methods:
Demographic data and anthropometric measurements will be collected on the day of visit. Fasting blood samples will be collected for measurement of plasma glucose, insulin, triglycerides, GIP, GLP-1, PYY (total), ghrelin (total). VAS for hunger and satiety will be completed in the fasting state. Participants will then consume a test meal of ~700 kcal consisting of protein and fat (no carbohydrates) within 10 minutes. Blood samples will be drawn and VAS scales completed postprandially at 30, 60, 90, 120, 150, 180 min. RMR measurements using indirect calorimetry will be performed in the fasting state, 1 hour and 3 hours postprandially to assess meal induced thermogenesis. Postprandial responses for these parameters will be assessed as area under the curve (AUC).
Patients with T1DM treated with basal- bolus insulin therapy will receive their regular basal insulin dose and patients on an insulin pump will be kept on their basal rate of insulin infusion. In case of fasting hyperglycemia, the session will be canceled.
Postrpandial glucose excursion will be treated with fast acting insulin.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alexandros Kokkinos
- Phone Number: +302132061248
- Email: rjd@otenet.gr
Study Locations
-
-
-
Athens, Greece, 11527
- Recruiting
- Diabetes Clinical Research Laboratory, 1st Department of Propaedeutic Internal Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Type 1 diabetes
- BMI >30 kg/m2 for the obese groups
Exclusion Criteria:
- Diabetic neuropathy
- Malignancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Lean patients with type 1 diabetes
Test meal consumed within 10 minutes
|
A test meal of ~700 kcal consisting of protein and fat will be consumed within 10 minutes
|
EXPERIMENTAL: Obese patients with type 1 diabetes
Test meal consumed within 10 minutes
|
A test meal of ~700 kcal consisting of protein and fat will be consumed within 10 minutes
|
ACTIVE_COMPARATOR: Lean healthy control subjects
Test meal consumed within 10 minutes
|
A test meal of ~700 kcal consisting of protein and fat will be consumed within 10 minutes
|
ACTIVE_COMPARATOR: Obese healthy control subjects
Test meal consumed within 10 minutes
|
A test meal of ~700 kcal consisting of protein and fat will be consumed within 10 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gut peptide hormone responses
Time Frame: 3 hours
|
Postprandial responses of ghrelin, PYY, GLP-1, Glicentin, Oxyntomodulin measured as area under the curve (AUC)
|
3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Meal induced thermogenesis
Time Frame: 3 hours
|
Change in basal metabolic rate after meal consumption as assessed by indirect calorimetry
|
3 hours
|
Collaborators and Investigators
Investigators
- Principal Investigator: Alexandros Kokkinos, First Department of Propaedeutic Medicine, Laiko General Hospital
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GutT1DM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Fundació Sant Joan de DéuNot yet recruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted
Clinical Trials on Standardized test meal
-
SciMar Ltd.Source Nutraceutical, Inc.CompletedNon-Diabetic | Females Who Are Not Pregnant or Breast FeedingCanada
-
Rijnstate HospitalUniversity College DublinCompleted
-
University of BernDCB Research AG; Insel Gruppe AG, University Hospital BernRecruitingDiabetes MellitusSwitzerland
-
Universidad de GranadaRecruiting
-
Institut National de la Santé Et de la Recherche...Completed
-
University of PennsylvaniaActive, not recruiting
-
University Hospital, Basel, SwitzerlandCompletedEndocrine System DiseasesSwitzerland
-
Odense University HospitalCompleted
-
Federico II UniversityCompleted
-
Laval UniversityCompleted